Proto Labs receives a Buy rating, driven by robust Q2 results and accelerating operating leverage. PRLB's CNC Machining and Injection Molding segments are outpacing industry CAGRs, signaling sustained
Proto Labs NYSE: PRLB reported record second-quarter revenue as demand strengthened in CNC machining and injection molding, while management raised its full-year growth outlook and highlighted progres